ES2534734B1 - Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal - Google Patents

Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal Download PDF

Info

Publication number
ES2534734B1
ES2534734B1 ES201331405A ES201331405A ES2534734B1 ES 2534734 B1 ES2534734 B1 ES 2534734B1 ES 201331405 A ES201331405 A ES 201331405A ES 201331405 A ES201331405 A ES 201331405A ES 2534734 B1 ES2534734 B1 ES 2534734B1
Authority
ES
Spain
Prior art keywords
response
colorectal cancer
predict
chemotherapy treatment
cancer patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
ES201331405A
Other languages
English (en)
Other versions
ES2534734A1 (es
Inventor
Rocío GARCÍA CARBONERO
Purificación ESTEVEZ GARCÍA
Luis PAZ-ARES RODRÍGUEZ
Sonia MOLINA PINELO
Amancio CARNERO MOYA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacion Publica Andaluza Para La Gestion de la Investigacion En Salud En Sevilla
Fund Publica Andaluza Para La Gestion de la Investig En Salud En Sevilla
Consejo Superior de Investigaciones Cientificas CSIC
Universidad de Sevilla
Servicio Andaluz de Salud
Original Assignee
Fundacion Publica Andaluza Para La Gestion de la Investigacion En Salud En Sevilla
Fund Publica Andaluza Para La Gestion de la Investig En Salud En Sevilla
Consejo Superior de Investigaciones Cientificas CSIC
Universidad de Sevilla
Servicio Andaluz de Salud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion Publica Andaluza Para La Gestion de la Investigacion En Salud En Sevilla, Fund Publica Andaluza Para La Gestion de la Investig En Salud En Sevilla, Consejo Superior de Investigaciones Cientificas CSIC, Universidad de Sevilla, Servicio Andaluz de Salud filed Critical Fundacion Publica Andaluza Para La Gestion de la Investigacion En Salud En Sevilla
Priority to ES201331405A priority Critical patent/ES2534734B1/es
Priority to PCT/ES2014/070731 priority patent/WO2015044495A1/es
Priority to US15/024,689 priority patent/US20160304961A1/en
Priority to EP14848032.0A priority patent/EP3050975A4/en
Publication of ES2534734A1 publication Critical patent/ES2534734A1/es
Application granted granted Critical
Publication of ES2534734B1 publication Critical patent/ES2534734B1/es
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Abstract

Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal.#Método de obtención de datos útiles para predecir la respuesta al tratamiento con quimioterapia en pacientes con cáncer colorrectal, kit, dispositivo y microarray para llevar a cabo dicho método.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32
imagen33
imagen34

Claims (1)

  1. imagen1
    imagen2
    imagen3
ES201331405A 2013-09-26 2013-09-26 Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal Withdrawn - After Issue ES2534734B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES201331405A ES2534734B1 (es) 2013-09-26 2013-09-26 Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal
PCT/ES2014/070731 WO2015044495A1 (es) 2013-09-26 2014-09-26 Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal
US15/024,689 US20160304961A1 (en) 2013-09-26 2014-09-26 Method for predicting the response to chemotherapy treatment in patients suffering from colorectal cancer
EP14848032.0A EP3050975A4 (en) 2013-09-26 2014-09-26 Method for predicting the response to chemotherapy treatment in patients suffering from colorectal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201331405A ES2534734B1 (es) 2013-09-26 2013-09-26 Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal

Publications (2)

Publication Number Publication Date
ES2534734A1 ES2534734A1 (es) 2015-04-27
ES2534734B1 true ES2534734B1 (es) 2016-02-09

Family

ID=52742127

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201331405A Withdrawn - After Issue ES2534734B1 (es) 2013-09-26 2013-09-26 Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal

Country Status (4)

Country Link
US (1) US20160304961A1 (es)
EP (1) EP3050975A4 (es)
ES (1) ES2534734B1 (es)
WO (1) WO2015044495A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2792150A1 (es) * 2019-05-06 2020-11-10 Fundacion Para La Investig E Innovacion Biosanitaria Principado De Asturias Metodo para predecir y/o diagnosticar la metastasis del cancer
CN111518909B (zh) * 2020-05-19 2022-07-01 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） Mettl2基因在制备检测结直肠癌氟尿嘧啶类药物治疗敏感性的试剂盒中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
WO2008045133A2 (en) * 2006-03-03 2008-04-17 Veridex, Llc Molecular assay to predict recurrence of dukes' b colon cancer
WO2009002175A1 (en) * 2007-06-28 2008-12-31 Agendia B.V. A method of typing a sample comprising colorectal cancer cells
EP2202320A1 (en) * 2008-12-24 2010-06-30 Agendia B.V. Methods and means for typing a sample comprising colorectal cancer cells
US20120046186A1 (en) * 2010-08-20 2012-02-23 Pelham Robert J Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs
US10036070B2 (en) * 2010-12-23 2018-07-31 Agendia N.V. Methods and means for molecular classification of colorectal cancers

Also Published As

Publication number Publication date
US20160304961A1 (en) 2016-10-20
ES2534734A1 (es) 2015-04-27
EP3050975A1 (en) 2016-08-03
WO2015044495A1 (es) 2015-04-02
EP3050975A4 (en) 2017-06-21

Similar Documents

Publication Publication Date Title
FI20135248L (fi) Mobiililaite transaktioinformaation kera
BR112016010095A2 (pt) ácidos nucleicos de célula livre para a ánalise de microbioma humano e componentes do mesmos.
BR112016011392A2 (pt) Técnicas para o fornecimento de informação de configuração com base em características de célula
DK2956483T3 (da) Terapeutisk og diagnostisk mål for cancer omfattende dll3-bindende reagenser
DK2941633T3 (da) Assayapparater, fremgangsmåder og reagenser
EP3058546A4 (en) METHOD AND DEVICE FOR SHARING INFORMATION
JP2013188229A5 (es)
EP2960808A4 (en) SERVER DEVICE, PRIVATE SEARCH PROGRAM, RECORDING MEDIA AND PRIVATE SEARCH SYSTEM
BR112015007265A2 (pt) método, meio de armazenamento legível por computador não transitório, aparelho.
BR112016009958A2 (pt) dispositivo microfluídico, método, sistema e kit
HK1225477A1 (zh) 用於通過使用量化手段來預測皮膚年齡的設備和方法
DK3079719T3 (da) ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf
HK1204686A1 (en) Method for obtaining information about program performance consumption, device and system thereof
EP2971132A4 (en) FABRIC AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, FORECASTING AND PREDICTING THE METASTAS POTENTIAL IN COLOR LECTAL CANCER
PL3389047T3 (pl) Urządzenie, sposób i program do analizy predykcji liniowej oraz nośnik zapisu
JP2016025466A5 (es)
TWI560437B (en) Fluorescence excitation device and portable fluorescence analysis system with the same
JP2015109010A5 (es)
SG11201600640RA (en) Systems, devices, media, and methods for measuring analytes in biological fluids
SG11201506666VA (en) Navigational analysis device, navigational analysis method, program, and recording medium
ES2534734B1 (es) Método para predecir la respuesta al tratamiento con quimioterapia en pacientes de cáncer colorrectal
EP3032854A4 (en) METHOD FOR DETERMINING INFORMATION AND DEVICE THEREOF
EP3088895A4 (en) Method for analyzing information for diagnosis and kit therefor
JP2014071113A5 (es)
DK3288979T3 (da) IGF-1R-antistof og anvendelse deraf til diagnosticering af cancer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2534734

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20160209

FA2A Application withdrawn

Effective date: 20160630